Syros Pharmaceuticals logo

Syros Pharmaceuticals

By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients

88 employees · est. 2012 · Cambridge, United States

VS
xMD Diagnostics, Inc. logo

xMD Diagnostics, Inc.

Enabling precision diagnostics

2 employees · est. 2017 · Baltimore, United States

Syros Pharmaceuticals is the older company (2012 vs 2017); Syros Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Syros Pharmaceuticals xMD Diagnostics, Inc.
Founded
2012 older 2017
Headquarters
Cambridge, United States Baltimore, United States
Employees
88 larger 2
Industry
Biotechnology, Life Sciences, Pharmaceutical Biotechnology, Health Care
Funding Stage
IPO Non Equity Assistance
Total Funding
$494.90M $356.00K
Funding Rounds
11 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Gene Expression Control, Hematologic Malignancies, Small Molecule Therapeutics, RARα Agonist, Myelodysplastic Syndrome, RARA Gene Overexpression, Oncology, Gene Regulatory Circuits, Drug Discovery, Bioinformatics, Assay Technologies, Genomic Data Integration, Biologic Insights Molecular Diagnostics, Precision Diagnostics, Laboratory Instruments, Consumables, Research, Biopharmaceutical, Clinical Laboratory, Pathology, Oncology, Physicians, Cancer Diagnosis, Genetic Diseases, Precision Medicine
Website
syros.com xmddiagnostics.com
Syros Pharmaceuticals logo

About Syros Pharmaceuticals

Syros Pharmaceuticals, founded in 2012, is a trailblazer in the Biotechnology and Pharmaceutical industries, known for its mission: "By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients". Headquartered in the United States, Syros is...

xMD Diagnostics, Inc. logo

About xMD Diagnostics, Inc.

xMD Diagnostics, Inc. is a molecular diagnostics tool company with a focus on developing laboratory instruments and consumables for the rapidly growing research, biopharmaceutical, and commercial clinical laboratory (CLIA) precision diagnostics markets. Founded in 2017 and headquartered in the Unite...

We will tell you when either one moves

BounceWatch watches Syros Pharmaceuticals and xMD Diagnostics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Syros Pharmaceuticals and xMD Diagnostics, Inc. — by email.

Frequently Asked Questions

Syros Pharmaceuticals — By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients. xMD Diagnostics, Inc. — Enabling precision diagnostics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Syros Pharmaceuticals has raised $494.90M while xMD Diagnostics, Inc. has raised $356.00K.
Syros Pharmaceuticals and xMD Diagnostics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Syros Pharmaceuticals with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Syros Pharmaceuticals on 27 May 2026, and xMD Diagnostics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy